Pharmabiz

China NMPA approves Antengene’ IND application for phase Ib/II study of ATG-022 in combo with Keytruda± chemotherapy

China NMPA approves Antengene’ IND application for phase Ib/II study of ATG-022 in combo with Keytruda± chemotherapy: Shanghai Wednesday, December 3, 2025, 18:00 Hrs [IST] Ante ...
Pharmabiz

Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure

Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure: Geneva Wednesday, December 3, 2025, 17:00 Hrs [IST] The Zambia Medicin ...
Pharmabiz

Citius Oncology launches US FDA approved Lymphir, a novel cancer immunotherapy for cutaneous T-cell lymphoma

Citius Oncology launches US FDA approved Lymphir, a novel cancer immunotherapy for cutaneous T-cell lymphoma: Cranford, New Jersey Wednesday, December 3, 2025, 16:00 Hrs [IST] Cit ...
Pharmabiz

Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia

Bayer initiates phase III study SUNFLOWER with long-acting reversible intrauterine system for treatment of nonatypical endometrial hyperplasia: Berlin Wednesday, December 3, 2025, ...
Pharmabiz

AstraZeneca’s NDA for baxdrostat accepted under US FDA Priority Review in US for patients with hard-to-control hypertension

AstraZeneca’s NDA for baxdrostat accepted under US FDA Priority Review in US for patients with hard-to-control hypertension: Cambridge, UK Wednesday, December 3, 2025, 09:00 Hrs ...
Pharmabiz

Exporters to strengthen supply chain independence as MSMEs struggle to meet revised Schedule M deadline

Exporters to strengthen supply chain independence as MSMEs struggle to meet revised Schedule M deadline: Shardul Nautiyal, Mumbai Wednesday, December 3, 2025, 08:00 Hrs [IST] Even ...
Pharmabiz

GSK to present new data from its haematology portfolio at the 67th ASH Annual Meeting and Exposition

GSK plc will present new data from its haematology portfolio at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition (6 - 9 December), reinforcing its potential to redefine ...
Pharmabiz

KSRPA urges govt to establish a dedicated veterinary drug cell within state FDA

KSRPA urges govt to establish a dedicated veterinary drug cell within state FDA: Nandita Vijayasimha, Bengaluru Wednesday, December 3, 2025, 08:00 Hrs [IST] The Karnataka State Re ...
Pharmabiz

Exporters report gradual recovery amidst depreciation of local currencies in Africa

Despite lingering cash flow strains for MSMEs, pharma exporters have reported gradual recovery amidst depreciation of local currencies in Africa supported by RBI's rupee trade mechanisms. Exporters ...
Pharmabiz

Roche gets US FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough

Roche gets US FDA clearance with CLIA waiver and CE Mark for its first point-of-care test for diagnosing Bordetella infections, including whooping cough: Basel Wednesday, December ...
Pharmabiz

CDSCO releases risk classification for 119 radiotherapy devices

CDSCO releases risk classification for 119 radiotherapy devices: Gireesh Babu, New Delhi Wednesday, December 3, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control Organisati ...
Pharmabiz

Expert calls for complete overhaul of India’s health education regulatory system

Expert calls for complete overhaul of India’s health education regulatory system: Peethaambaran Kunnathoor, Chennai Wednesday, December 3, 2025, 08:00 Hrs [IST] A high-impact po ...